Wolverine Trading’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $273K | Buy |
30,500
+8,400
| +38% | +$65.3K | ﹤0.01% | 4520 |
|
|
2025
Q2 | $140K | Buy |
+22,100
| New | +$126K | ﹤0.01% | 4067 |
|
|
2025
Q1 | – | Sell |
-44,600
| Closed | -$413K | – | 5002 |
|
|
2024
Q4 | $413K | Sell |
44,600
-48,300
| -52% | -$443K | ﹤0.01% | 3621 |
|
|
2024
Q3 | $696K | Buy |
+92,900
| New | +$845K | ﹤0.01% | 2727 |
|
|
2024
Q2 | – | Sell |
-11,000
| Closed | -$27.8K | – | 4634 |
|
|
2024
Q1 | $27.8K | Sell |
11,000
-4,300
| -28% | -$9.69K | ﹤0.01% | 4310 |
|
|
2023
Q4 | $36.7K | Buy |
+15,300
| New | +$36K | ﹤0.01% | 4317 |
|
|
2023
Q3 | – | Sell |
-11,200
| Closed | -$85.3K | – | 4640 |
|
|
2023
Q2 | $85.3K | Buy |
+11,200
| New | +$104K | ﹤0.01% | 3823 |
|
|
2023
Q1 | – | Sell |
-14,800
| Closed | -$175K | – | 4412 |
|
|
2022
Q4 | $175K | Buy |
14,800
+2,900
| +24% | +$44.9K | ﹤0.01% | 3213 |
|
|
2022
Q3 | $247K | Sell |
11,900
-800
| -6% | -$22.3K | ﹤0.01% | 3347 |
|
|
2022
Q2 | $388K | Buy |
12,700
+6,200
| +95% | +$212K | ﹤0.01% | 2790 |
|
|
2022
Q1 | $272K | Sell |
6,500
-4,600
| -41% | -$203K | ﹤0.01% | 4021 |
|
|
2021
Q4 | $501K | Buy |
11,100
+700
| +7% | +$31.7K | ﹤0.01% | 3450 |
|
|
2021
Q3 | $538K | Sell |
10,400
-3,100
| -23% | -$188K | ﹤0.01% | 3829 |
|
|
2021
Q2 | $864K | Buy |
13,500
+9,000
| +200% | +$578K | ﹤0.01% | 2958 |
|
|
2021
Q1 | $406K | Sell |
4,500
-6,800
| -60% | -$696K | ﹤0.01% | 4029 |
|
|
2020
Q4 | $1.05M | Buy |
11,300
+2,200
| +24% | +$202K | ﹤0.01% | 2318 |
|
|
2020
Q3 | $949K | Buy |
+9,100
| New | +$981K | ﹤0.01% | 2138 |
|
|
2019
Q2 | – | Sell |
-6,300
| Closed | -$318K | – | 4553 |
|
|
2019
Q1 | $318K | Buy |
6,300
+2,000
| +47% | +$118K | ﹤0.01% | 3295 |
|
|
2018
Q4 | $252K | Buy |
+4,300
| New | +$277K | ﹤0.01% | 3410 |
|
|
2016
Q3 | – | Sell |
-14,300
| Closed | -$403K | – | 4683 |
|
|
2016
Q2 | $403K | Buy |
+14,300
| New | +$561K | ﹤0.01% | 2449 |
|
Other funds holding EBS
OHA
PCM
